BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33962358)

  • 1. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.
    Zhu G; Su H; Johnson CH; Khan SA; Kluger H; Lu L
    Eur J Cancer; 2021 Jul; 151():25-34. PubMed ID: 33962358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
    Fang S; Xu T; Xiong M; Zhou X; Wang Y; Haydu LE; Ross MI; Gershenwald JE; Prieto VG; Cormier JN; Wargo J; Sui D; Wei Q; Amos CI; Lee JE
    J Invest Dermatol; 2019 Nov; 139(11):2352-2358.e3. PubMed ID: 31176707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of Immune Infiltrates in Primary Melanoma.
    Gartrell RD; Marks DK; Hart TD; Li G; Davari DR; Wu A; Blake Z; Lu Y; Askin KN; Monod A; Esancy CL; Stack EC; Jia DT; Armenta PM; Fu Y; Izaki D; Taback B; Rabadan R; Kaufman HL; Drake CG; Horst BA; Saenger YM
    Cancer Immunol Res; 2018 Apr; 6(4):481-493. PubMed ID: 29467127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
    Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
    Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
    Torphy RJ; Sun Y; Lin R; Caffrey-Carr A; Fujiwara Y; Ho F; Miller EN; McCarter MD; Lyons TR; Schulick RD; Kedl RM; Zhu Y
    Nat Commun; 2022 Jan; 13(1):97. PubMed ID: 35013216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.
    Zhang J; Tao J; Gao RN; Wei ZY; He YS; Ren CY; Li QC; Liu YS; Wang KW; Yang G; Qian C; Chen JH
    Front Immunol; 2021; 12():715559. PubMed ID: 34539647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.
    Kuklinski LF; Yan S; Li Z; Fisher JL; Cheng C; Noelle RJ; Angeles CV; Turk MJ; Ernstoff MS
    Cancer Immunol Immunother; 2018 Jul; 67(7):1113-1121. PubMed ID: 29737375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Cremonesi E; Governa V; Garzon JFG; Mele V; Amicarella F; Muraro MG; Trella E; Galati-Fournier V; Oertli D; Däster SR; Droeser RA; Weixler B; Bolli M; Rosso R; Nitsche U; Khanna N; Egli A; Keck S; Slotta-Huspenina J; Terracciano LM; Zajac P; Spagnoli GC; Eppenberger-Castori S; Janssen KP; Borsig L; Iezzi G
    Gut; 2018 Nov; 67(11):1984-1994. PubMed ID: 29437871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic features of tumour-infiltrating CD4
    Parrot T; Oger R; Allard M; Desfrançois J; Raingeard de la Blétière D; Coutolleau A; Preisser L; Khammari A; Dréno B; Delneste Y; Guardiola P; Fradin D; Gervois N
    Sci Rep; 2020 Apr; 10(1):5900. PubMed ID: 32246006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
    J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients.
    De Logu F; Galli F; Nassini R; Ugolini F; Simi S; Cossa M; Miracco C; Gianatti A; De Giorgi V; Rulli E; Cossu A; Massi D; Mandalà M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.
    Gordon-Alonso M; Hirsch T; Wildmann C; van der Bruggen P
    Nat Commun; 2017 Oct; 8(1):793. PubMed ID: 28986561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
    Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
    Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.
    Rothermel LD; Sabesan AC; Stephens DJ; Chandran SS; Paria BC; Srivastava AK; Somerville R; Wunderlich JR; Lee CC; Xi L; Pham TH; Raffeld M; Jailwala P; Kasoji M; Kammula US
    Clin Cancer Res; 2016 May; 22(9):2237-49. PubMed ID: 26712692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients.
    Massi D; Romano E; Rulli E; Merelli B; Nassini R; De Logu F; Bieche I; Baroni G; Cattaneo L; Xue G; Mandalà M
    Eur J Cancer; 2017 Jun; 78():70-81. PubMed ID: 28412591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.